Santi Roque A
Known title: DirectorCIK: 0001316254
Associated companies
Transaction History
| AX | ▼ Sell | Open Market | 500 | $53K | 8/5/2026 | View on chart |
| AX | ▼ Sell | Open Market | 500 | $44K | 5/8/2026 | View on chart |
| AX | ▲ Buy | Option Exercise | 4,289 | $339K | 11/14/2025 | View on chart |
| AX | ▼ Sell | Other | 2,144 | $170K | 11/14/2025 | View on chart |
| AX | ▲ Buy | Option Exercise | 6,000 | $417K | 8/31/2024 | View on chart |
| AX | ▼ Sell | Other | 2,999 | $208K | 8/31/2024 | View on chart |
| AX | ▲ Buy | Option Exercise | 6,000 | $254K | 9/15/2023 | View on chart |
| AX | ▼ Sell | Other | 3,000 | $127K | 9/15/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Axos Financial Faces Valuation Debate Amid Analyst Support
Recent commentary highlights a divide in how Axos Financial is viewed, with some analysts citing limited margin of safety despite strong bank fundamentals. Meanwhile, Needham reiterated its positive stance with a $128 price target. The stock currently trades near its 52-week low, reflecting broader market caution around high-beta financial names.
Axos Financial Faces Valuation Debate Amid Analyst Support. Recent commentary highlights a divide in how Axos Financial is viewed, with some analysts citing limited margin of safety despite strong bank fundamentals. Meanwhile, Needham reiterated its positive stance with a $128 price target. The stock currently trades near its 52-week low, reflecting broader market caution around high-beta financial names.